SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-295648
Filing Date
2021-10-08
Accepted
2021-10-08 17:19:05
Documents
17
Period of Report
2021-10-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d419423d8k.htm   iXBRL 8-K 29897
2 EX-1.1 d419423dex11.htm EX-1.1 241302
3 EX-1.2 d419423dex12.htm EX-1.2 236550
4 EX-5.1 d419423dex51.htm EX-5.1 11368
5 EX-99.1 d419423dex991.htm EX-99.1 8313
9 GRAPHIC g419423g1008133400641.jpg GRAPHIC 2479
  Complete submission text file 0001193125-21-295648.txt   793039

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cdtx-20211007.xsd EX-101.SCH 2874
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdtx-20211007_lab.xml EX-101.LAB 18139
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdtx-20211007_pre.xml EX-101.PRE 11396
10 EXTRACTED XBRL INSTANCE DOCUMENT d419423d8k_htm.xml XML 3363
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 211316084
SIC: 2836 Biological Products, (No Diagnostic Substances)